BioProcessing Summit Europe
March 22-24, 2022
FUJIFILM Diosynth Biotechnologies is delighted to be a Corporate Sponsor at BioProcessing Summit Europe, March 22-24, 2022, Barcelona, Spain. Stop by our booth #8 and meet with our team to learn more about FUJIFILM Diosynth Biotechnologies’ capabilities and how we can help you advance and deliver tomorrow’s medicines.
Join our Presentations
Wednesday – March 23, 2022, Joanna Norman, PhD., Senior Staff Scientist, Viral Gene Therapy Process Development group, FUJIFILM Diosynth Biotechnologies, UK will be presenting: Strategies to Propel Your Viral Vector Therapy from the Lab to the Clinic.
- Gene therapies offer exciting avenues as curative therapies for unmet patient needs. Often these therapies are expected to advance rapidly through clinical stages. Moving from lab to clinic in a timely, predictable way requires companies to develop robust, scalable and reproducible processes. This talk will discuss how leveraging a manufacturing platform can expedite the critical path from clinical to commercialization, focusing on FUJIFILM Diosynth Biotechnologies’ AAV platform and supporting phase-appropriate analytical methods.
Thursday – March 24, 2022, Rachel Richer, Staff Scientist, Cell line Development group, FUJIFILM Diosynth Biotechnologies, UK will be presenting: A Versatile Expression System for Accelerated DNA to Product Timelines
- ApolloX™ is a cell line development platform, incorporating next-generation screening technology, enhanced media selection, and technical expertise. The technology supports aggressive cell line development timelines, whilst ensuring robust and high quality cell lines are obtained. Also described here is a ‘manufacturability assessment’ strategy, which is performed both in-silico using a proprietary bioinformatics tool (Orbit™) together with material generated from transfectant pools, and used to evaluate platform-fit for multiple candidate molecules.